PSM India aims to: raise awareness of spurious drugs' harm; educate consumers and practitioners on drug quality and identifying suspected spurious drugs; and collaborate with the government and WHO. PSM held an international workshop on ensuring patient safety over commercial interests and regaining consumer confidence. A study found many small manufacturers lack Good Manufacturing Practices compliance and risk producing spurious drugs. It evaluated 348 essential drugs across India to understand the spurious drug problem's full extent and compliance with regulations. PSM plans to expand detection technologies statewide and work with regulators against law-violating manufacturers.

1. PSM India Presentation
Bejon Misra
Founder and Head
Partnership for Safe Medicines India

2. What are the goals of
PSM India?
• To raise public awareness of the harm to patient safety
caused by spurious drugs
• To raise consumer and distributor awareness of the
existence and extent of spurious drugs
• To work collaboratively with the medical community
• To educate Indian consumers on the importance of drug
quality, how to identify suspected spurious drugs, and
what actions to take when encountering a suspected case
• To educate community healthcare practitioners in
drugstores and health centers on the problem of spurious
drugs and what role they can play to lessen the problem
2

3. PSM India’s
International
Workshop
• Collaboration with
✦
✦
✦
Government of India
World Health Organization
Partnership for Safe Medicines India
• Insuring Patient Safety Prevails over
Commercial Interest
• Regaining Consumer Confidence
3

4. Study:
The Extent of Spurious Drugs in the
Supply Chain of Indian Market
• 10,000 Manufacturers –
How many meet GMP?
– Small scale manufacturers
are the greatest risk
– Better to shape up than face
the consequences
4

5. Goals of the Study:
• To enable assessment of the drugs available in
India for compliance with regulations pertaining to
pharmaceopoeial standards and spurious drugs as
defined in the regulation.
• To understand the extent of the spurious drug
problem across the entire country.
Medicines to be Evaluated
348 Essential Drugs –TB, malaria, HIV, cancer,
diabetes, infection, all major therapeutic areas
5

6. Expanding to
Local Indian States
• design a strategy to implement the use of
detection and authentication technologies to
make spurious and unsafe medicines easily
detectable
• take prompt action against all such
manufacturers who violate the laws and
standards of our country by working closely
with the State Regulators and law enforcers
6

7. Coming Up at 1:15pm
• Panel 3
Bringing Criminals
to Justice Across
Jurisdictions